title: FDA approves three different multiple myeloma drugs in one month.
authors: Mark
authors: M
authors: Ratner
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001896:Boron Compounds; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005998:Glycine / Q000031:analogs & derivatives*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001896:Boron Compounds; C546027:elotuzumab; C556306:daratumumab; C548400:ixazomib; D005998:Glycine